N9’s special offerings provide antiviral performance against the coronavirus bringing proven hygiene function and material protection to the textile industryN9 World Technologies, India signed an agreement with Consolidated Pathways Inc., USA to incorporate unique Swiss antiviral and antimicrobial technologies into sustainable, cost-effective custom blends for the textile industry. N9’s special offerings provide antiviral performance against the coronavirus bringing proven hygiene function and material protection to the textile industry, says a press release. This partnership will now allow both companies to offer unique performance benefit platforms to the global textile industry. This new antiviral technology will be marketed under the umbrella brand VIROBAN and is very effective against the enveloped and capsid viruses. Vikram Rao, managing director of N9 World Technologies said, “With the onslaught of the pandemic, consumers are increasingly seeking protection and safety in almost everything they breathe, touch or wear.

Source: Dhaka Tribune August 10, 2020 11:48 UTC